选择性ER-phagy通过调节帕金森症模型中的α-synuclein清除产生神经保护作用
Dong Yeol Kim1, Jin Young Shin1,2, Ji Eun Lee1
1Department of Neurology, Yonsei University College of Medicine, Seoul 03722, South Korea.
概括
细胞内膜网膜 (ER) -phagy降解了与帕金森病 (PD) 相关的蛋白质α-synuclein. 增强ER-phagy保护神经元并改善运动功能,这表明PD的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 细胞内膜网膜 (ER) 恒常状态是由ER-phagy维持的.
- 在ER中的α-synuclein积累导致ER压力,并导致帕金森病 (PD) 神经退行.
- 对于ER-phagy在调节α-synuclein水平中的作用尚不清楚.
研究的目的:
- 研究ER-phagy在选择性α-synuclein降解中的机制.
- 在PD模型中探索增强ER-phagy的治疗潜力.
主要方法:
- 使用分子生物学技术研究了ER-phagy在α-synuclein清除中的作用.
- 在ER-phagy通路中利用了FAM134B和calnexin相互作用.
- 在PD模型的黑色物质 (SN) 中使用了α-synuclein和FAM134B的过度表达模型.
主要成果:
- ER-phagy对于降解α-synuclein和通过FAM134B恢复ER功能至关重要.
- 在FAM134B介导的α-synuclein清除中,calnexin是必不可少的.
- 在SN中过度表达的α-synuclein导致多巴胺基神经元损失和运动缺陷.
- 在SN中FAM134B过度表达提供了神经保护和改善了运动性能.
结论:
- ER-phagy选择性地降解α-synuclein,为帕金森病提供了潜在的治疗策略.
- 针对ER-phagy通路,特别是通过FAM134B,显示了PD中神经保护的希望.
更多相关视频
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.0K
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
10.7K
相关概念视频
01:37Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
01:15Parkinson's Disease: Overview
593
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
593
01:24Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K